Video

Cholesterol Drugs

Babies in the Womb May Already Be Learning Language

Some Doctors Prescribe Antibiotics Because Parents Want Them

What Kids Wear Could Determine How Much Exercise They Get

Few College Students Have Received the H1N1 Vaccine

Night Lights Could Lead to Depression

Cervarix Has Been Approved by the FDA

The FDA Is Studying the Effects of Lasik Surgery

Painkillers Can Dull the Effects of Childhood Vaccines

Childbirth May Becoming More Complicated

Botox Sponges Might Help Nose Allergies

The FDA Advises on How to Properly Dispose of Medicine

A French Study Shows Cell Phones Do Not Affect Humans

MRIs May Lead to More Back Surgery

Your More Likely to Wash Your Hands If Someone's Watching

Votrient Approved for Advanced Kidney Cancer

Posted on 10/20/2009, 10:34
By -- Scott Roberts

Designed to thwart blood vessel growth in tumors

TUESDAY, Oct. 20 (HealthDay News) -- Votrient (pazopanib) has been approved to treat advanced renal cell carcinoma, a form of kidney cancer in which cancerous cells invade the lining of small tubes in the kidney called tubules, the U.S. Food and Drug Administration said in a news release.

The oral drug is designed to prevent angiogenesis, the growth of blood vessels that tumors need to survive. Five other drugs have been approved to treat kidney cancer since 2005, the agency said.

This year, some 49,000 people have been diagnosed with renal cell carcinoma and 11,000 have died, the FDA said.

In a 435-person clinical trial, the time before a tumor began re-growing or the patient died averaged 9.2 months for people taking Votrient, compared with 4.2 months among those who didn't take the drug.

Possible adverse reactions to Votrient include diarrhea, high blood pressure, hair color changes, nausea, vomiting, fatigue, abdominal pain and headache. The drug also can be highly toxic to the liver, so people taking Votrient should have their liver function closely monitored, the FDA said. The medication also can cause heart rhythm problems.

Since it can harm a fetus, the drug shouldn't be used by pregnant women, the agency said.

Votrient is produced by the British drug maker GlaxoSmithKline.

More information

The FDA has more about this approval.

More news in Kidney Health...

BigHealthTree.com Disclaimer

Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.

Rating: 2.7 / 5 (11 votes)